Earnings · China A-shares
HeiLongJiang ZBD Pharmaceutical Co., Ltd. Class A (603567) earnings
HeiLongJiang ZBD Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit -29.30% year on year, -21.10% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +7.86% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -29.30%
- Excl. one-offs YoY
- -21.10%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.31% | — |
| 3 days | +7.86% | — |
| 7 days | +8.73% | — |
| 14 days | -6.11% | — |
Report history
Over the last 8 reports, net profit grew year on year in 0 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +2.41%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥482.41M | -29.30% | -21.10% | -55.68% | -0.51 | -7.99% | +7.86% | — | — |
| 2026 interim report | 2026-08-29 | -¥270.97M | -246.12% | — | -58.60% | -0.29 | -4.41% | -2.23% | -13.92% | -4.58% |
| 2026 Q1 report | 2026-04-30 | -¥179.95M | -338.99% | — | -61.29% | -0.19 | -2.91% | +6.30% | -11.24% | -13.30% |
| 2025 annual report | 2026-04-30 | -¥1.37B | -411.84% | — | -70.51% | -1.45 | -19.33% | +6.30% | -11.24% | -13.30% |
| 2025 Q3 report | 2025-10-28 | -¥373.10M | -193.81% | — | -54.73% | -0.40 | -4.90% | +0.99% | -8.27% | -4.89% |
| 2025 interim report | 2025-08-28 | -¥78.29M | -119.90% | — | -57.05% | -0.08 | -1.01% | -1.78% | -2.51% | -8.01% |
| 2025 Q1 report | 2025-04-30 | ¥75.30M | -74.33% | -74.23% | -58.03% | 0.08 | 0.96% | +3.32% | +8.63% | +5.45% |
| 2024 annual report | 2025-04-30 | ¥438.22M | -7.30% | +1365.50% | -13.90% | 0.47 | 5.70% | +3.32% | +8.63% | +5.45% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.